Osiris Therapeutics, Inc. (NASDAQ:OSIR)

CAPS Rating: 1 out of 5

A stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas.

Recs

0
Player Avatar ayuddha (< 20) Submitted: 7/15/2012 5:18:50 PM : Outperform Start Price: $10.25 OSIR Score: -13.40

It was picked by www.hechtsoft.de Trade Alerts.

Featured Broker Partners


Advertisement